# Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)

> **NCT06572423** · NA · RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 43 (estimated)

## Conditions studied

- Head and Neck Carcinoma
- Localized Head and Neck Carcinoma
- Metastatic Head and Neck Carcinoma
- Recurrent Head and Neck Carcinoma

## Interventions

- **PROCEDURE:** Personalized ultrafractionated stereotactic adaptive radiotherapy
- **RADIATION:** Volume Modulated Arc Therapy
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Magnetic Resonance Imaging
- **OTHER:** Best Practice
- **BEHAVIORAL:** University of Washington Quality of Life Scale, Version 4
- **BEHAVIORAL:** Functional Assessment of Cancer Therapy-Head & Neck

## Key facts

- **NCT ID:** NCT06572423
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-25
- **Primary completion:** 2028-12-16
- **Final completion:** 2029-12-16
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06572423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06572423, "Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06572423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*